logo
Share SHARE
FONT-SIZE Plus   Neg

Abbott To Buy AP214 From Action Pharma - Quick Facts

Abbott (ABT: Quote) and Action Pharma A/S, a privately owned company, have reached an agreement in which Abbott would acquire AP214 from Action Pharma. The company said this acquisition would enhance Abbott's pipeline in renal care. Abbott has two investigational treatments in development for chronic kidney disease.

Pursuant to the deal, Abbott would buy all global rights to develop and commercialize AP214 for the prevention of AKI and other relevant indications. Abbott would provide a cash payment of $110 million to Action Pharma and woul be responsible for funding all future development and commercialization activities regarding AP214. No later milestone payments or royalties would be paid to Action Pharma.

Abbott expects to incur a one-time specified item in the second quarter of 2012, related to this payment.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Mixed signal solutions provider NXP Semiconductors N.V. (NXPI) agreed Sunday to acquire embedded processing solutions provider Freescale Semiconductor Ltd (FSL) in a cash an stock deal valued at about $16.7 billion, including Freescale's net debt of $4.9 billion. Get ahead of the market. For in-depth... Mitel Networks Corp. (MITL, MNW.TO) and Mavenir Systems (MVNR) announced a merger agreement in which Mitel will acquire all of the outstanding shares of Mavenir common stock in a cash and stock deal valued at approximately $560 million. Get ahead of the market. For in-depth analysis not... ISIS has renewed its death threat to employees of micro-blogging site Twitter, Inc., particularly its co-founder Jack Dorsey. The threats are in retaliation for Twitter blocking accounts which are affiliated to or support the Islamic State. Twitter has a policy of barring users from posting threats or using the service for furthering of illegal activities.
comments powered by Disqus
RELATED NEWS
Trade ABT now with 
Follow RTT